Gardner E J, Woodward S R, Hughes J P
Cancer Genet Cytogenet. 1985 Feb 15;15(3-4):321-34. doi: 10.1016/0165-4608(85)90177-3.
Hereditary adenomatosis, particularly familial polyposis coli (FPC) and Gardner's syndrome (GS), has been investigated from family pedigrees and chromosomal markers for precancer and cancer. FPC and GS are much alike in phenotypes. Studies are in progress to determine if the two adenomatous diseases are controlled by the same DNA sequence. Chromosome numerical and structural instability is a good diagnostic criterion for hereditary adenomatous diseases where risk factors are already determined to the level of 0.5 probability from pedigree analysis. This has been applied successfully at the pediatric age level to identify family members who carry the gene but have no adenomas in the colorectum. Sister chromatid exchange (SCE) did not distinguish plasma samples from FPC, GS, or solitary adenoma patients form each other or from controls with no adenomas. SCE did distinguish invasive from recurrent and noninvasive cancer. The chromosome #2 polymorphism observed at 2q-21.3 has not been confirmed as a deletion, but is under investigation with more refined methods.
遗传性腺瘤病,尤其是家族性腺瘤性息肉病(FPC)和加德纳综合征(GS),已通过家族谱系和染色体标记对癌前病变和癌症进行了研究。FPC和GS在表型上非常相似。正在进行研究以确定这两种腺瘤性疾病是否由相同的DNA序列控制。染色体数量和结构不稳定性是遗传性腺瘤性疾病的良好诊断标准,其中通过谱系分析已将危险因素确定到0.5概率水平。这已成功应用于儿童年龄组,以识别携带该基因但结肠直肠中无腺瘤的家庭成员。姐妹染色单体交换(SCE)无法区分FPC、GS或孤立性腺瘤患者的血浆样本与彼此或与无腺瘤的对照样本。SCE确实区分了浸润性癌与复发性和非浸润性癌。在2q-21.3观察到的2号染色体多态性尚未被确认为缺失,但正在用更精细的方法进行研究。